HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rep. Pallone Readying Cosmetics Bill Following EWG Nail Ingredient Study

This article was originally published in The Rose Sheet

Executive Summary

A new study from the Environmental Working Group and Duke University links common nail polish ingredient triphenyl phosphate to elevated levels in user's blood of a metabolite suspected of endocrine disruption. The Personal Care Products Council calls the study "speculative" and "misleading," while Rep. Frank Pallone, D-N.J., says its results signal a need for new legislation to update cosmetics regulations.

You may also be interested in...

CIR's Draft Review Priorities Reflect International Activity, NGO Targets

The Cosmetic Ingredient Review Expert Panel is set to finalize its list of ingredient priorities for review in 2017 at its June 6-7 meeting in Washington.

Teen Study Promoting Switch To 'Free Of' Cosmetics Causes Usual Row

Teenage girls who used personal-care products free of phthalates, parabens, triclosan and benzophenone-3 showed reduced levels of those substances in their urine after three days, according to a study published in Environmental Health Perspectives. Industry's and NGOs' divergent views on the study reflect continuing disagreement as to how chemical safety should be assessed.

Rep. Pallone Inquires Into WEN Safety Concerns With Cosmetics Bill In The Works

In letters to Guthy-Renker and FDA leadership, House Democrat Frank Pallone probes for information regarding the safety of WEN Cleansing Conditioner, which he says has been linked to 17,000 complaints from consumers suffering hair loss and other adverse reactions. Cosmetics are "largely unregulated," according to the congressman, but he's working on legislation to reform the oversight framework.

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts